Shodikulova G. Z (1), Pulatov U. S (2), Karimov A. Kh. (3)
Interest in the problem of gout is associated with its high prevalence and rapid growth among men and women of working age. In the study, 75 patients with primary gout were examined. The average age of the patients was 55.9±8 years (ranging from 29 to 65 years). It has been substantiated that it is necessary to conduct a comparative analysis of articular syndrome with liver and kidney damage in patients with gout.
1. Abhishek A, Valdes AM, Jenkins W, Zhang W, Doherty M. Triggers of acute attacks of gout, does age of gout onset matter? A primary care based cross-sectional study. PLoS One. 2017 Oct 12;12(10):e0186096. doi:10.1371/journal.pone.0186096.
PMID: 29023487; PMCID: PMC5638318.
2. Adashek ML, Bourji KI. Pegloticase Induced Hemolytic Anemia in a Patient With G6PD Deficiency. J Hematol. 2018 May;7(2):83-85. doi:10.14740/jh402w. Epub 2018 May 10. PMID: 32300419; PMCID: PMC7155862.
3. Alghubayshi A, Edelman A, Alrajeh K, Roman Y. Genetic assessment of hyperuricemia and gout in Asian, Native Hawaiian, and Pacific Islander subgroups of pregnant women: biospecimens repository cross-sectional study. BMC Rheumatol. 2022 Jan 6;6(1):1. doi:10.1186/s41927-021-00239-7. PMID: 34986901; PMCID: PMC8734301.
4. Alrajeh KY, Roman YM. Pharmacogenetic Perspective for Optimal Gout Management. Future Pharmacol. 2022;2:135–152. doi:10.3390/futurepharmacol2020011.
5. Amatucci AJ, Padnick-Silver L, LaMoreaux B, Bulbin DH. Comparison Between Early-Onset and Common Gout: A Systematic Literature Review. Rheumatol Ther. 2023 Aug;10(4):809-823. doi:10.1007/s40744-023-00565-x. Epub 2023 Jun 19. PMID: 37335432; PMCID: PMC10326179.
6. Beringer PM, Kriengkauykiat J, Zhang X, Hidayat L, Liu S, Louie S, et al. Lack of effect of P-glycoprotein inhibition on renal clearance of dicloxacillin in patients with cystic fibrosis. Pharmacotherapy. 2008 Jul;28(7):883-94. doi:10.1592/phco.28.7.883. PMID: 18576903.
7. Bezalel Y, Gershoni-Baruch R, Dagan E, Lidar M, Livneh A. The 3435T polymorphism in the ABCB1 gene and colchicine unresponsiveness in familial Mediterranean fever. Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S103-4. PMID: 19796545.
8. Borić-Bilušić AA, Božina N, Lalić Z, Lovrić M, Nađ-Škegro S, Penezić L, Barišić K, Trkulja V. Loss of Function ABCG2 c.421C>A (rs2231142) Polymorphism Increases Steady-State Exposure to Mycophenolic Acid in Stable Renal Transplant Recipients: An Exploratory Matched Cohort Study. Adv Ther. 2023 Feb;40(2):601-618. doi:10.1007/s12325-022-02378-w. PMID: 36434147.
9. Bortolotti M, Polito L, Battelli MG, Bolognesi A. Xanthine oxidoreductase: One enzyme for multiple physiological tasks. Redox Biol. 2021 May;41:101882. doi:10.1016/j.redox.2021.101882. PMID: 33578127; PMCID: PMC7879036.
10. Bowden RG, Richardson KA, Richardson LT. Uric acid and metabolic syndrome: Findings from national health and nutrition examination survey. Front Med (Lausanne). 2022 Dec 14;9:1039230. doi:10.3389/fmed.2022.1039230. PMID: 36590930; PMCID: PMC9795410.
11. Brigham MD, Milgroom A, Lenco MO, Wang Z, Kent JD, LaMoreaux B, et al. Immunosuppressant Use and Gout in the Prevalent Solid Organ Transplantation Population. Prog Transplant. 2020 Jun;30(2):103-110. doi:10.1177/1526924820913514. PMID: 32208882.
12. Cai N, Chen M, Feng P, Zheng Q, Zhu X, Yang S, Zhang Z, Wang Y. Relationships between obesity and prevalence of gout in patients with type 2 diabetes mellitus: a cross-sectional population-based study. BMC Endocr Disord. 2024 Aug;24(1):137. doi:10.1186/s12902-024-01672-8. PMID: 39090627.
13. Cai N, Chen M, Wu L, Feng P, Ye X, Liu Q, Zhu X, et al. Association between physical activity and the prevalence of gout among patients with type 2 diabetes mellitus and hyperuricemia: a two-center population-based cross-sectional study. Clin Rheumatol. 2024 Sep;43(9):2955-2961. doi:10.1007/s10067-024-07081-5. PMID: 39060811.
14. Cao L, Zhao T, Xie C, Zheng S, Wan W, Zou H, Zhu X. Performance of Ultrasound in the Clinical Evaluation of Gout and Hyperuricemia. J Immunol Res. 2021 Apr 5;2021:5550626. doi:10.1155/2021/5550626. PMID: 33884273; PMCID: PMC8041551.
15. Card-Gowers J, Retat L, Kumar A, Marder BA, Padnick-Silver L, LaMoreaux B, et al. Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study. Rheumatol Ther. 2024 Aug;11(4):913-926. doi:10.1007/s40744-024-00681-2. PMID: 38836994.
16. Carroll MB, Smith DM, Shaak TL. Genomic sequencing of uric acid metabolizing and clearing genes in relationship to xanthine oxidase inhibitor dose. Rheumatol Int. 2017 Mar;37(3):445-453. doi:10.1007/s00296-016-3592-2. PMID: 27798726.